RxDoctor Payments DataLook up a doctor →

Belton Hallmark, MD

Family Medicine · Castle Rock, CONPI 1225018633

Payments from drug & device makers

$18,744in general payments, 2019–2025

Across 698 payments — averaging $26.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • AstraZeneca$2K
  • Amgen$1K
  • Novo Nordisk$1K
  • Alkermes, Inc.$977
  • Otsuka America Pharmaceutical, Inc.$837
  • plus $9K from 53 others

What the payments were for

  • Food & beverage$18,725100%
  • Education$190%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)120$2,911
AstraZeneca69$2,489
Amgen(2 entities)68$1,458
Novo Nordisk49$1,223
Alkermes, Inc.20$977
Otsuka America Pharmaceutical, Inc.25$837
Eisai Inc.26$640
Amarin Pharma, Inc.36$526
Neurocrine Biosciences, Inc.11$476
Lilly USA, LLC28$472
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)11$383
Edwards Lifesciences8$355
Bayer14$350
Idorsia Pharmaceuticals US Inc10$338
Bausch Health US, LLC17$336
Biohaven Pharmaceuticals, Inc.10$327
Phathom Pharmaceuticals, Inc.6$315
Esperion Therapeutics, Inc.5$297
Biohaven Pharmaceutical Holding Company Ltd.8$295
Therapeuticsmd, Inc.4$283
Novartis12$270
Daiichi Sankyo Inc.8$224
Kowa Pharmaceuticals America, Inc.13$216
Avanir Pharmaceuticals, Inc.11$206
Pfizer11$201
Johnson & Johnson6$186
Merck6$182
Lucid Diagnostics Inc.5$172
Takeda Pharmaceuticals U.S.A., Inc.8$165
Astellas Pharma US Inc2$143
Abiomed1$117
Harmony Biosciences LLC1$113
Axsome Therapeutics, Inc.5$109
Corium, LLC5$99
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC7$95
Jazz Pharmaceuticals Inc.5$81
Lundbeck LLC4$80
Aimmune Therapeutics, Inc.4$77
Seqirus USA Inc3$66
Fidia Pharma USA Inc.4$66
Nevro Corp.3$60
Paratek Pharmaceuticals, Inc.3$58
Boston Scientific3$57
Sunovion Pharmaceuticals Inc.4$56
GSK2$43
Shire North American Group Inc2$42
Insulet Corporation2$30
Teva Pharmaceuticals USA, Inc.2$28
Amneal Pharmaceuticals LLC1$27
Boehringer Ingelheim1$26
Exact Sciences1$25
Sumitomo Pharma America, Inc.1$25
Hologic Sales And Service, LLC1$22
Endo Pharmaceuticals Inc.1$17
Ultragenyx Pharmaceutical Inc.1$16
Alfasigma USA, Inc.1$16
Azurity Pharmaceuticals, Inc.1$16
Upsher-smith Laboratories LLC1$14
Medicure Pharma Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,744 in reported general payments places this provider in the 95th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$160,092
Medicare patients
251
Services billed
7,810

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide79$95,191
EliquisApixaban48$57,548
MounjaroTirzepatide34$49,722
JardianceEmpagliflozin38$42,253
KerendiaFinerenone31$28,163
VascepaIcosapent Ethyl46$27,813
TrulicityDulaglutide22$21,529
Repatha SureclickEvolocumab30$20,933
MyrbetriqMirabegron29$13,764
EntrestoSacubitril/Valsartan14$10,537
LinzessLinaclotide12$9,293
SymbicortBudesonide/Formoterol Fumarate21$6,949
Repatha PushtronexEvolocumab11$6,529
Olmesartan Medoxomil146$4,812
Eszopiclone87$4,179

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,223$95,19179 claims
Lilly USA, LLCMounjaro, Trulicity$472$71,25156 claims
PfizerEliquis$201$57,54848 claims
Boehringer IngelheimJardiance$26$42,25338 claims
BayerKerendia$350$28,16331 claims
Astellas Pharma US IncMyrbetriq$143$13,76429 claims
NovartisEntresto$270$10,53714 claims
AbbVieLinzess$2,911$9,29312 claims
AstraZenecaSymbicort$2,489$6,94921 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$27$2,267213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Castle Rock

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →